Adenocarcinoma  >>  glufosfamide (D 19575)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glufosfamide (D 19575) / Eleison Pharma
NCT00099294 / 2004-001363-22: Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Completed
3
300
US, Europe, RoW
Glufosfamide
Threshold Pharmaceuticals, PPD
Pancreatic Cancer
01/07
01/07

Download Options